# Case Report: D-bifunctional protein deficiency caused by novel compound heterozygote HSD17B4 variants in a neonate in China

**Authors:** Hui Liu, Gaojie Liu, Lianjun Gao, Hui Wang, Yizhong Wang, Hongfang Ding

PMC · DOI: 10.3389/fgene.2025.1631767 · 2025-11-06

## TL;DR

A Chinese neonate was diagnosed with a rare genetic disorder caused by new mutations in the HSD17B4 gene, leading to severe neurological and developmental issues.

## Contribution

The study reports novel compound heterozygous HSD17B4 mutations in a Chinese neonate with D-bifunctional protein deficiency.

## Key findings

- The patient had novel compound heterozygous HSD17B4 mutations (c.1145G>A and c.1193C>G) not previously reported.
- Elevated levels of very-long-chain fatty acids (VLCFAs) confirmed the diagnosis of D-bifunctional protein deficiency.
- The neonate exhibited severe developmental delays and neurological impairments at 7 months of age.

## Abstract

D-bifunctional protein deficiency (D-BPD) is a rare fatal autosomal recessive peroxisomal disorder caused by biallelic pathogenic mutations in the hydroxysteroid 17-beta dehydrogenase 4 (HSD17B4) gene; it is characterized by hypotonia, seizures, and facial dysmorphisms during the neonatal period.

In this report, we describe a female neonate from China who was diagnosed with D-BPD. The patient presented with neonatal asphyxia, hypotonia, weak reflexes, and feeding difficulty after birth. Seizures occurred on the fifth day of life and were initially treated with phenobarbital. However, the seizures reoccurred and became more difficult to control because of their increased frequency, duration, and anticonvulsive drug resistance. Whole-genome sequencing (WGS) revealed novel compound heterozygous mutations c.1145G>A(p.Gly382Asp)/c.1193C>G(p.Ser398*) in exon 13 of the HSD17B4 gene, which was confirmed by parental Sanger sequencing. Neither variant has been reported previously. Very-long-chain fatty acid (VLCFA) testing revealed markedly elevated levels of hexacosanoic acid (C26:0), tetracosanoic acid/docosanoic acid (C24:0/C22:0), and C26:0/C22:0. The patient was managed with formula nasogastric feeding and antiepileptic therapy. At 7 months of age, she demonstrated severe psychomotor retardation, inability to grasp and manipulate objects, no language development, hearing loss, and poor visual response.

We described the incidence of D-BPD in a Chinese neonate caused by novel biallelic pathogenic variants in HSD17B4, which expands its mutational spectrum.

## Linked entities

- **Genes:** HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4) [NCBI Gene 3295]
- **Chemicals:** hexacosanoic acid (PubChem CID 10469), tetracosanoic acid (PubChem CID 11197), docosanoic acid (PubChem CID 8215)
- **Diseases:** D-bifunctional protein deficiency (MONDO:0009855), peroxisomal disorder (MONDO:0019053)

## Full-text entities

- **Genes:** HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4) [NCBI Gene 3295] {aka DBP, MFE-2, MFP-2, MPF-2, PRLTS1, SDR8C1}
- **Diseases:** Seizures (MESH:D012640), facial dysmorphisms (MESH:C565579), D-BPD (OMIM:261515), hypotonia (MESH:D009123), psychomotor retardation (MESH:D011596), neonatal asphyxia (MESH:D001237), hearing loss (MESH:D034381), autosomal recessive peroxisomal disorder (MESH:D018901)
- **Chemicals:** tetracosanoic acid (MESH:C010210), C26:0 (MESH:C017364), C24:0 (-), C22:0 (MESH:C007547), phenobarbital (MESH:D010634)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Ser398*, c.1145G>A, c.1193C>G

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12631431/full.md

---
Source: https://tomesphere.com/paper/PMC12631431